Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices

GLP-1 Price Index & Weight Loss Statistics (November 2026)

Disclosure: we may earn a commission when you click a provider link. It never affects our rankings, prices or verdicts, which come from verified sources.

The dated, citable record of what 12US telehealth providers publish for compounded semaglutide and tirzepatide - every price verified against the provider’s own site, every change logged - paired with the published clinical-trial results for GLP-1 weight-loss medications (STEP, SURMOUNT, SCALE).

Prices verified November 3, 2026 · 14 logged changes since September 14, 2026

Medically reviewed on

How we review

The short answer

In the pivotal trials, semaglutide 2.4 mg (Wegovy) produced about 15% mean weight loss at 68 weeks and tirzepatide 15 mg (Zepbound) up to 22.5% at 72 weeks, against about 2.4% on lifestyle-only placebo in STEP 1. At verified published prices, 12 US telehealth providers list compounded semaglutide from $41 to $199 a month and compounded tirzepatide from $69 to $299, last checked November 3, 2026. Results typically peak around months 12 to 16, and about two-thirds of the lost weight returned within a year of stopping in the STEP 1 extension.

Treatments Hub original data

What does compounded GLP-1 actually cost? A 12-provider price survey

We track published prices across 12 US telehealth providers. As of November 2026, compounded semaglutide ranged from $41 to $199 per month and compounded tirzepatide from $69 to $299 per month - a fraction of the brand-name list prices for the same active ingredients, which run into four figures (below). Every figure is a price the provider publishes, verified by our team - not an estimate.

Brand medicationActive ingredientBrand list priceCompounded from
OzempicSemaglutide$1,149-$1,399/mo$41/mo
ZepboundTirzepatide$1,249-$1,599/mo$69/mo
WegovySemaglutide$1,579-$1,799/mo$41/mo

Source: Treatments Hub GLP-1 price index, 12 providers, verified published prices as of November 2026. Brand list prices are manufacturer/pharmacy list prices; insurance and manufacturer coupons can lower them. See the full provider-by-provider table on our cheapest GLP-1 comparison.

What does each of the 12 providers charge? The index, verified November 3, 2026

Each row records the headline monthly price and the condition attached to it - a promotional rate, a plan length, a prepaid term. A price is never listed without its condition. Sorted by semaglutide price, cheapest first.

ProviderSemaglutide /moConditionTirzepatide /moConditionCommitment
welludr$41pre-Black Friday sale (shown on welludr's site, Nov 3, 2026); 12-month plan; previously $49$71pre-Black Friday sale (shown on welludr's site, Nov 3, 2026); shipped every 4 weeks; previously $8912-month plan for the lowest rate; cancel or change anytime
embody$49sale price, flat month to month; site shows a countdown to a price increase (Nov 3, 2026)$99sale price, flat month to monthNone - month to month, cancel anytime
altRxfrom $89starting pricefrom $149starting priceNone - pause or cancel anytime; Buy Now, Pay Later
HealthRxfrom $9712-month plan; $99 first month on the monthly plan; 3-month $125, 6-month $115from $17712-month plan; $99 first month on the monthly plan; 3-month $201, 6-month $19512-month plan for the lowest rate; monthly, 3- and 6-month plans also offered
Collective$59same price at every dose; plus $199/year membership (21-day free trial)$69same price at every dose; plus $199/year membership (21-day free trial)Month to month, no multi-month orders, cancel anytime; membership billed annually after the trial
Eden$99flat every month, same price at every dose$129flat every month, same price at every doseNone - no membership, no annual or long-term plan
Sproutfrom $9912-month plan, $1,188 billed upfront; monthly $149, no commitmentfrom $14912-month plan, $1,788 billed upfront; monthly $199, no commitmentNo membership fee; monthly option with no commitment; plans renew until cancelled
MedviPlans from $99"start for just $99"; no membership or hidden fees; dietician visits and care coaching included; no separate price per medication publishedNone - no membership or hidden fees; HSA/FSA
DirectMedsPlans from $147starting price; same price at every dose; no separate price per medication publishedNone - no membership, cancel anytime
TrimRxPlans from $149weight loss plans starting at $149; no separate price per medication publishedMonth to month - cancel before your next billing cycle
bmiMD$1493-month plan ($447); limited-time price$1593-month plan ($477); limited-time price3-month plan shown; 12-, 6- and 1-month plans also offered
SHEDfrom $199starting pricefrom $299starting priceNone - HSA/FSA approved

Compounded medications are prepared by state-licensed pharmacies and are not FDA-approved brand products. Every provider listed requires a licensed-clinician review before prescribing. Prices are cash-pay; confirm current terms on each provider’s site.

Which prices changed, and when?

The full dated feed, with each provider’s current listing, is on GLP-1 price changes.

Every time a verification pass changes a listing, the change is recorded here with the date, what we listed before, and what we list now. Newest first.

  1. November 11, 2026

    Collective

    Newly listed. Compounded semaglutide $59/month and tirzepatide $69/month, the same price at every dose, month to month with no multi-month orders. A $199 annual membership (billed yearly, 21-day free trial) covers unlimited doctor messaging, check-ins and 2-day express cold shipping; averaged over a year it adds about $16.58 a month.

  2. November 3, 2026

    Sprout

    Lowest listed price now on the 12-month plan: compounded semaglutide from $99/month and tirzepatide from $149/month, billed upfront ($1,188 and $1,788 for 52 weeks). Previously listed from $149 and $199, which remain Sprout's monthly, no-commitment prices. 6- and 3-month plans sit in between (semaglutide $110 and $125, tirzepatide $160 and $180); same price at any dose.

  3. November 3, 2026

    HealthRx

    Lowest listed rates now from $97/month for compounded semaglutide (previously $99, listed as a 12-month prepaid plan) and from $177/month for tirzepatide (previously from $179), both on the 12-month plan. The monthly plan is $99 for the first month; 3- and 6-month plans are also offered (semaglutide $125 and $115, tirzepatide $201 and $195).

  4. November 3, 2026

    Eden

    Added to the tracker: compounded semaglutide $99/month and tirzepatide $129/month, the same price every month and at every dose, with no membership and no annual or long-term plan.

  5. November 3, 2026

    bmiMD

    Added to the tracker at its 3-month plan price, shown as a limited-time price: compounded semaglutide $149/month ($447 for 3 months) and tirzepatide $159/month ($477), the same price at every dose. Prices for the 12-, 6- and 1-month plans were not captured.

  6. November 3, 2026

    TrimRx

    Listing now shows TrimRx's published "plans starting at $149". Its site does not show a separate tirzepatide price, so the $259/month tirzepatide figure from our earlier check is no longer listed.

  7. November 3, 2026

    Medvi

    Listing now shows Medvi's published "start for just $99", with no membership or hidden fees and dietician visits and coaching included. Its page does not show a separate tirzepatide price, so the $166/month promotional tirzepatide figure from our earlier check is no longer listed.

  8. November 3, 2026

    DirectMeds

    Listing now shows DirectMeds' published "starting at $147", the same price at every dose. Its page does not tie the price to one medication, so we no longer list $147 separately for semaglutide and tirzepatide.

  9. October 28, 2026

    welludr

    Pre-Black Friday sale: compounded semaglutide now listed from $41/month (previously $49) and tirzepatide from $71/month (previously $89) on the 12-month plan, the same price at every dose, per welludr's partner pricing notice of October 28; the provider says the rate holds for the immediate future with no end date stated.

  10. October 28, 2026

    embody

    Pre-Black Friday sale: compounded semaglutide now listed at $49/month (previously $69) and tirzepatide at $99/month (previously $119), month to month with no commitment, per the banner on embody's site. Published regular prices remain $79 and $129; no end date is stated.

  11. September 21, 2026

    altRx

    Promotional $89/month semaglutide and $149/month tirzepatide rates extended: provider now lists the sale as ending September 25 (previously September 20). Prices unchanged.

  12. September 15, 2026

    TrimRx

    Compounded semaglutide now listed at $149/month, the same price at every dose ($140 discount applied). Previously listed as $179 for the first month and $299 regular thereafter. Tirzepatide unchanged at $259/month.

  13. September 14, 2026

    altRx

    Promotional $89/month semaglutide and $149/month tirzepatide rates confirmed; provider lists the sale as ending September 20. Regular rates remain $199 and $299.

  14. September 14, 2026

    welludr

    Compounded semaglutide now listed at $49/month on the 12-month plan (previously listed $59) and tirzepatide at $89/month (previously $99). Same price at every dose.

Our top 2 picks

Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review

How much weight do GLP-1 medications cause on average?

MedicationActive IngredientAvg. Weight LossTrial
WegovySemaglutide 2.4mg~15% of body weightSTEP 1
ZepboundTirzepatide 15mgUp to 22.5% of body weightSURMOUNT-1
OzempicSemaglutide 2mg~6-8% of body weightSUSTAIN (type 2 diabetes)
MounjaroTirzepatide 15mg~12-15% of body weightSURPASS (type 2 diabetes)
SaxendaLiraglutide 3mg~5-8% of body weightSCALE

Source: Pivotal published trials - STEP 1 (Wilding et al., New England Journal of Medicine, 2021) for semaglutide 2.4mg; SURMOUNT-1 (Jastreboff et al., NEJM, 2022) for tirzepatide 15mg; SCALE (Pi-Sunyer et al., NEJM, 2015) for liraglutide 3mg; SUSTAIN program for semaglutide 2mg. Figures are trial averages; individual results vary.

What these averages mean in pounds, who reaches 10% or 20%, and the head-to-head result: GLP-1 weight loss results, trial by trial.

What are the most common GLP-1 side effects?

Side EffectSemaglutideTirzepatide
Nausea~40-44%~25-33%
Diarrhea~30%~19-23%
Vomiting~24%~8-13%
Constipation~23%~12-17%

Source: FDA prescribing information and pivotal-trial safety data (STEP and SURMOUNT programs). Rates are approximate; side effects typically improve over time and with dose stabilization.

How fast does weight loss happen on a GLP-1?

TimeframeWhat to Expect
Week 1-2Reduced appetite, early satiety, possible mild nausea
Month 13-5 lbs weight loss (starting dose)
Month 2-3~3-6% body weight loss as the dose increases
Month 610-15% body weight loss (semaglutide) or 15-20% (tirzepatide)
Month 12-16Maximum results: 15% (semaglutide) to 22.5% (tirzepatide)

Source: Clinical trial averages. Individual results vary based on medication, dose, diet, and exercise.

Who Qualifies for GLP-1 Treatment?

According to FDA-approved prescribing criteria, GLP-1 weight loss medications are indicated for adults with:

  • BMI ≥ 30 (obesity)
  • BMI ≥ 27 with at least one weight-related condition (type 2 diabetes, hypertension, high cholesterol, sleep apnea)

Who should not take them

Semaglutide and tirzepatide carry an FDA boxed warning for thyroid C-cell tumors and are contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. They are also used with caution in people with a history of pancreatitis or gallbladder disease, and are not for use in pregnancy. Always review your full history with a licensed clinician.

Read our complete eligibility guide or take our quiz to check if you qualify.

What are the key facts about GLP-1 weight loss?

  • Among the most effective prescription weight-loss options: in STEP 1, semaglutide 2.4 mg produced about 15% mean weight loss versus roughly 2.4% in the lifestyle-only (placebo) arm - a substantially larger effect than older weight-loss drugs.
  • Once-weekly injection: Both Wegovy (semaglutide) and Zepbound (tirzepatide) are administered as once-weekly subcutaneous injections.
  • Two daily pills are now approved too: the Wegovy pill (oral semaglutide 25 mg, December 2025) and Foundayo (orforglipron, April 2026) produced 13.6% and 11.2% mean weight loss in their own trials (OASIS 4 at 64 weeks; ATTAIN-1 at 72 weeks), which are not head to head. See Foundayo vs the Wegovy pill.
  • Gradual dose escalation: Treatment starts at a low dose and increases monthly over 16-20 weeks to minimize side effects.
  • Available online: Licensed telehealth providers can prescribe GLP-1 medications through fully online medical evaluations, with home delivery in most US states.
  • Weight regain risk: The STEP 1 trial extension showed approximately two-thirds of weight lost was regained within one year of stopping semaglutide, supporting the case for ongoing treatment.
  • Dual-agonist advantage: Tirzepatide targets both GLP-1 and GIP receptors, which may explain its superior weight loss results compared to semaglutide.

How was this data gathered, and how should you cite it?

Pricing: our price survey tracks the prices 12US telehealth providers publish for compounded semaglutide and tirzepatide. Every figure is a published provider price verified by our team against the provider’s own site - we do not estimate, model or extrapolate prices. The index was last verified on November 3, 2026, and every change to a listing is recorded in the change log above with its date.

Clinical data:weight-loss and safety figures are drawn from the medications’ pivotal published trials (STEP, SURMOUNT, SCALE, SUSTAIN) and FDA prescribing information, and are trial averages rather than guarantees of individual results.

Citing this page?Please attribute to “Treatments Hub GLP-1 Price Index (2026)” and link to this page. For the full provider-by-provider pricing table, see our cheapest GLP-1 comparison. This page is general information, not medical advice.

More GLP-1 guides

The rest of our weight-loss medication guides, kept to the same verified-price standard.

Compare GLP-1 Providers

See how the top telehealth weight loss providers compare on pricing, medications, and support.